This website will be unavailable from Thursday, May 30, 2024 at 6:00 p.m. through Monday, June 3, 2024 at 7:00 a.m. due to data center maintenance.
Amend CSHB 2050 (house committee printing) as follows:
(1) On page 1, line 7, strike "Subsection (c-1)" and substitute "Subsections (c-1) and (c-2)".
(2) On page 1, strike lines 15 and 16 and substitute the following:
(2) the person prescribing the medication, [or] that person's designee, or the facility's medical director provided the following information, in a standard
(3) On page 2, line 18, strike "department" and substitute "commission".
(4) On page 2, between lines 19 and 20, insert the following:
(c-2) Written consent provided by a resident or the resident's legally authorized representative on the form described by Subsection (c-1) is presumed to satisfy the consent requirements of Subsection (c) and the disclosure requirements established by the Texas Medical Disclosure Panel in Sections 74.103 and 74.105, Civil Practice and Remedies Code.
SECTION 2. As soon as practicable after the effective date of this Act, the executive commissioner of the Health and Human Services Commission shall develop the form required by Section 242.505(c-1), Health and Safety Code, as added by this Act. In developing the form, the commission shall consult with the Texas Medical Disclosure Panel.
(5) On page 2, line 20, strike "SECTION 2" and substitute "SECTION 3".